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Abstract: There are differences in the allele frequency of MTHFR polymorphism between Western 
and African population. The aim of this study is to determinate the prevalence of MTHFR C677T and 
A1298C polymorphisms in young and old people living in different areas from Mediterranean to sub-
Saharan  areas.  The  observed  vs  expected  genotype  frequencies  of  677T  were  in  Hardy  Weinberg 
equilibrium,  with  the  exception  of  old  Sardinian  subjects  (P=0.02).  Calculation  of  677T  allele 
frequency in young and old African subjects (8% and 3%, respectively)  indicated that the 677T allele 
was disadvantaged in old Africans (P=0.02). The difference among young and old Sardinians and 
Sicilians  were not significant at the same degree (43% vs 37% P=0.07 and 46% vs 42% P=0.28, 
respectively). However, the reproducible trend that showed the prevalence of 677T allele in the young 
subjects of the three studied areas confirms the disadvantage of this polymorphism with the age. There 
was a significant difference (P=0.005) on the observed vs expected frequency of 1298C homozygosity 
in  African  old  subjects  compared  to  younger  ones,  while  the  observed  vs  expected  genotype 
frequencies were in equilibrium in young and old Sardinian and Sicilian subjects. The frequencies of 
1298C and 1298A alleles were comparable between young and old African, Sardinian and Sicilian 
subjects. The lower frequency of 677T allele in old African, Sardinian and Sicilian subjects compared 
to young ones and the absence of TT genotype among old African subjects, should be considered as a 
consequence of an elevated mortality of 677T carriers. 
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INTRODUCTION 
 
Methylenetetrahydrofolate  reductase  (MTHFR) 
catalyzes  the  conversion  of  5,10-
methylenetetrahydrofolate  to  5-methyltetrahydrofolate, 
which  is  needed  for  methionine  synthase  to  convert 
homocysteine (Hcy) to methionine
[1]. Its key function in 
Hcy metabolism makes this enzyme a hot point in the 
mechanism  which  associates  hyperhomocysteinemia 
(HHcy)  with  the  cardiovascular  risk  and  other 
pathologies  where  the  role  of  folate  is  largely 
documented
[2]. The MTHFR gene is polymorphic, with 
single nucleotide variants within codon 677 in exon 4 
(CT),  which  causes  an  alanine  to  valine  substitution, 
and  within  codon  1298  in  exon  7  (AC)  which 
determines  a  substitution  of  glutamate  by  an  alanine 
residue
[3,4].  The  codon  677  variant  encodes  a 
thermolabile enzyme with reduced activity that leads to 
an increase of plasma Hcy level
[5]. Individuals who are 
homozygous  for  the  codon  677  polymorphism  show 
hypomethylation  of  DNA  in  peripheral  blood 
leukocytes,  an  effect  that  is  especially  pronounced 
when folate levels are low
[6]. In western countries the 
C677T  polymorphism  may  result  in  the  necessity  to 
have  a  higher  folate  ingestion  to  reduce  the  plasma 
HHcy and it has been considered, especially in North 
Europe, a risk factor responsible of neural tube defects 
and  21  trisomy
[3,6,7].  The  homozygosity  CC  for  1298 
polymorphism  becomes  a  risk  factor  of  vascular 
disorders,  especially  with  the  individual’s  aging,  if 
associated with a decreased ingestion of folate
[8]. Also 
this  polymorphism  reduces  MTHFR  activity  and  has 
been reported to be a risk factor for neural tube defects 
(NTD)
[9],  but  this  mutation  is  rarely  associated  with 
significant  increasing  of  plasma  Hcy  levels
[10].  There 
are  differences  in  the  frequencies  of  this  allele  in 
Western  and  African  countries,  which  suggest  some 
selective  mechanism  which  act  prevalently  in  young 
age
[11-13]. A selective role of malaria could be supported 
by  the  homocysteine  (Hcy)  involvement  in  the 
Plasmodium falciparum metabolic cycle 
[14]. The aim of 
this study is to determinate the prevalence of 677T and Online J. Biol. Sci., 6 (1): 28-34, 2006 
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1298C  alleles  of  MTHFR  in  young  and  old  people 
living in different countries from Mediterranean to sub-
Saharan  areas  and  to  correlate  the  prevalence  of 
MTHFR  polymorphisms  with  social  and  economical 
status, nutritional characteristics, endemia or pregressed 
endemia for malaria. 
 
SUBJECTS AND METHODS 
 
Subjects: In a period from 1 April to 31 July 2005, 400 
subjects in each country (Burkina Faso,  Sardinia and 
Sicily), equally distributed among males and females, 
were submitted to a physical and clinical examination 
before they could be considered clinically healthy. All 
individuals  participating  to  the  first  selection  signed 
informed consent forms for blood and informative data 
collection. The local Ethical Committees both in Italy 
and in Burkina Faso approved this study. The health 
balance  was  evaluated  by  visiting  the  subjects  and 
collecting blood samples for routine tests. The weight, 
height, blood pressure, ECG, heart rate and ventilation 
rate  were  also  controlled.  Abnormal  laboratory 
parameters were considered essential exclusion criteria 
(elevated  blood  urea  nitrogen,  serum  cholesterol, 
altered urine analysis, high level of blood pressure, etc) 
for all participants. No variation of these parameters > 2 
SD  was admitted.  At the end of the examination, 18 
African,  5  Sardinian  and  26  Sicilian  were  excluded. 
Then  we  collected  blood  samples  of  documented 
healthy subjects without anamnestic pathologies in the 
last six months:  
–  191  African  young  subjects,  90  males  and  101 
females, aged 20-45 (average 25) years; 
– 191 African old subjects, 89 males and 102 females, 
aged 60-90 (average 71) years. 
–  200  Sardinian  young  subjects,  89  males  and  111 
females, aged 28-50 (average 38) years; 
– 195 Sardinian old subjects, 95 males and 100 females, 
aged 60-90 (average 72) years. 
– 194 Sicilian young subjects, 95 males and 99 females, 
aged 22-58 (average 43) years; 
– 180 Sicilian old subjects , 81 males and 99 females, 
aged 60-90 (average 72) years. 
All  subjects  were  born  from  African,  Sardinian  and 
Sicilian  parents  for  two  generations.  Against  a  slight 
prevalence of females on males, the power of sample 
reached the statistical significance for the evaluation of 
allele frequencies. All young and old individuals of the 
three areas were matched for sex and age respectively. 
African subjects, living in a poor social status, usually 
eat millet or sorghum flower with vegetable sauce and, 
once a week, chicken, pork, sheep or beef meat, never 
fish, local seasonal fruits, according to the habits of the 
country.  The  folic  acid  intake  was  insured  by  the 
presence of green vegetable in their diet. All were in 
good health  state.  All Sardinian and Sicilian subjects 
eat according to the Mediterranean diet and consume 
regularly  red  wine  at  lunch  and  dinner.  Also  the 
Mediterranean diet is rich in folates from its high green 
leafy  vegetable  content.  Their  social  status  was 
medially characteristic of western countries. 
 
Collection,  processing  of  blood  samples:  Blood 
samples (10 mL of peripheral blood: 5 mL in a plain 
tube and 5 mL in EDTA) were collected in the morning 
after over night fast. Tubes containing blood in EDTA 
were immediately centrifuged at 1500 g for 10 min at 
4°C, while tubes containing blood without an additive 
were  left  to  stand  at  room  temperature  for  30  min. 
Plasma and serum were then separated and stored at -
80°C (in 250 ￿L aliquots). Clinical chemistry tests of 
African  subjects  were  performed  by  the  central 
laboratory  of  Centre  Medical  St.  Camille  of 
Ouagadougou  using  standard  methods.  The  clinical 
chemistry tests of Sardinians and Sicilians were made 
in Sassari and Catania private laboratories, respectively, 
using  standard  methods.  Plasma  homocysteine  (Hcy), 
serum folate, vitamin B6 and vitamin B12 levels were 
measured  at  the  Clinical  Biochemistry  Laboratory  of 
Catholic University, Rome, Italy. The determination of 
plasma homocysteine was carried out by HPLC. Daily 
quality  control  was  carried  out  by  using  a  control 
sample prepared from a plasma pool processed at the 
beginning and at the end of the analytical session. The 
inter-assay coefficient of variation was 3.6. Plasma Hcy 
values > 15 mmol/L were considered elevated. Serum 
vitamin  B12  was  measured  by  micro  particle  enzyme 
immunoassay and serum folate by ion capture assay on 
an AxSYM Analyzer (Abbott Diagnostics, Abbott Park, 
USA).  The  inter-assay  coefficient  of  variation  was 
1.7%  for  both  vitamin  B12  and  folate.  A  folate  level 
<11.33  nmol/L  was  considered  hypofolatemia,  and  a 
serum  vitamin  B12  level  <115.86  pmol/L  was 
considered  low.  Vitamin  B6  was  measured  by  HPLC 
using a commercially available kit (Immunodiagnostik, 
Bensheim,  DE).  We  considered  vitamin  B6  values 
<20.23    nmol/L  to  be  low.  Packed  peripheral  blood 
containing leukocytes were frozen at -80°C and sent in 
dry  ice  to  the  Laboratory  of  Institute  of  Population 
Genetics,  Alghero,  Sassari,  Italy,  for  the  MTHFR 
polymorphism study. 
 
Genetic analysis:  Genomic DNA  was isolated from 
2.5  mL  of  packed  peripheral  blood  as  previously 
described
[15]. The C677T and the A1298C mutations in 
the MTHFR gene were analyzed after polymerase chain 
reaction  (PCR)  of  genomic  DNA.  The  regions 
containing  the  two  polymorphisms  were  amplified 
separately by using the following primer pairs: C677T 
forward-CTTGAACAGGTGGAGGCC;  reverse-
CAAAGAAAAGCTGCGTGATGAT  and  A1298C 
forward-GCAAGTCCCCCAAGGAGG;  reverse-
GGTCCCCACTTCCAGCATC.  DNA  was  amplified 
by  using  a  PCR  thermal  cycler  (GeneAmp9700, 
Applied Biosystems, Foster City, CA, USA). Both PCR 
were carried out in a total volume of 25 mL containingOnline J. Biol. Sci., 6 (1): 28-34, 2006 
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￿￿￿￿￿￿￿￿￿￿ ￿￿ ￿ ￿ ￿ ￿￿￿￿￿ ￿ ￿￿￿￿￿ ￿ ￿￿ ￿ ￿ ￿ ￿￿ ￿￿ ￿￿￿￿ ￿￿ ￿ ￿￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿￿ ￿￿ ￿￿ ￿ ￿ ￿￿￿￿￿ ￿ ￿￿ ￿ ￿ ￿ ￿￿￿ ￿ ￿ ￿￿ ￿ ￿￿￿￿ ￿ ￿￿￿ ￿￿￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿￿ ￿￿ ￿ ￿
Parameters￿ Young 
Africans 
(n. 191) (A)￿
Old 
Africans 
(n. 191) (B)￿
Young 
Sardinians 
(n. 200) (A)￿
Old 
Sardinians 
(n. 195) (B)￿
Young 
Sicilians 
(n. 194) (A)￿
Old 
Sicilians 
(n. 180) (B)￿
Age (years)￿ 25 (20-45)￿ 71 (60-90)￿ 38 (28-50)￿ 73 (60-90)￿ 43 (22-58)￿ 72 (60-90)￿
BMI  (Kg/m
2)￿ 25.2±1.4*￿ 24.2±2.6 ￿ 26.1±1.8*￿ 23.2±2.1￿ 25.9±1.9*￿ 22.5±2.0￿
Blood nitrogen (mmol/L)￿ 2.0±0.45*￿ 2.2±0.33 ￿ 2.85±0.34*￿ 3.2±0.43￿ 2.79±0.5*￿ 3.3±0.39￿
Serum cholesterol (mmol/L)￿ 4.56±0.89*￿ 4.51±0.82￿ 4.36±0.75*￿ 4.60±0.83￿ 4.35±0.88*￿ 4.64±0.84￿
Serum triglycerides (mmol/L)￿ 1.08±0.11*￿ 0.97±0.10 ￿ 1.10±0.13$￿ 1.13±0.15￿ 1.22±0.14$￿ 1.19±0.15￿
Serum creatinine (mmol/L)￿ 63.65±9.7*￿ 69.83±14.14￿ 78.4±13.5*￿ 87.8±12.5￿ 75.9±13.2*￿ 88.7±12.4￿
Cystatin C  (mg/L)￿ 0.69 ±0.08*￿ 0.86±0.24 ￿ 0.70±0.21*￿ 0.88±0.23￿ 0.73±0.22*￿ 0.89±0.21￿
Hcy  (mmol/L)￿ 6.8±4.2*￿ 12.2±5.7￿ 8.5±4.9*￿ 16.2±4.7￿ 8.6±4.6*￿ 16.4±5.2￿
Serum folate  (nmol/L)￿ 13.37±4.98￿ 13.37±5.1￿ 20.4±6.8￿ 21.6±5.7￿ 25.7±7.4￿ 24.3±6.5￿
Serum Vit B6  (nmol/L)￿ 26.7±11.7￿ 24.7±12.9￿ 28.2±15.3￿ 26.3±12.5￿ 28.4±12.3￿ 27.9±13.0￿
Serum Vit B12 (pmol/L)￿ 614.7±251.2^￿ 527.7±277.8￿ 527.2±255.2￿ 547.5±245.3￿ 538.3±262.1￿ 587.4±255.6￿
Systolic blood pressure  (mm Hg)￿ 132.0±14.2^￿ 139.9±22.5 ￿ 130.4±22.3*￿ 145.8±24.3￿ 134.3±25.2*￿ 146.3±23.2￿
Diastolic blood pressure  (mm Hg)￿ 82.0±13.4$￿ 79.5±13.6￿ 80.3±13.2$￿ 83.2±12.4￿ 79.9±13.1$￿ 83.8±13.9￿
￿ ￿ ￿ ￿ ￿￿ ￿ ￿￿￿￿￿￿ ￿ ￿￿￿ ￿￿ ￿ ￿￿ ￿￿ ￿  ￿! " ! ! ! ￿￿￿# ￿  ￿! " ! ! ￿￿￿$ ￿  ￿! " ! % ￿
 17.5 pmol of each primer, 200 mmol each dNTP/L, 
10 mmol Tris-HCl/L (pH 8.3), 1.5 mmol MgCl2/L, 50 
mmol  KCl/L,  0.75  U  of  Taq  polymerase  (Applied 
Biosystems,  Foster  City,  CA,  USA)  and  60  ng  of 
template DNA. The reaction conditions for the two 
fragments were as it follows: initial denaturation at 
95°C for 3 min, 32 subsequent cycles of denaturation 
at 95°C for 30 sec, annealing at 60°C for 30 sec and 
extension at 72°C for 45 sec and a final extension at 
72°C  for  10  min.  PCR  products  (10  mL)  were 
digested in a total volume of 20 mL with 2 U HinfI 
(for  nucleotide  677)  and  with  2  U  MboII  (for 
nucleotide 1298) (New England Biolabs Inc, USA). 
DNA fragments were separated by electrophoresis on 
a  4%  agarose  gel  in  TBE  1X  and  visualized  with 
ethidium bromide. 
 
Statistical  analyses:  Laboratory  parameters  are 
reported  as  mean  and  SD  and  the  difference  were 
compared  by  Student  T  and  Krustal  Wallis  tests. 
Allele  frequencies  for each  genotype and  the exact 
confidence  intervals  on  the  frequencies  were 
calculated.  Expected  genotype  frequencies  were 
calculated from the allele frequencies and compared 
to  observed  frequencies  under  the  assumption  of 
Hardy-Weinberg equilibrium. The difference among 
allele  frequencies  and  genotype  frequencies  were 
compared  with  appropriate  statistical  tests  (X
2  and 
Fisher exact test). The Pearson coefficient followed 
by Fisher exact test was used to test correlations. In 
all  statistical  evaluation  P<0.05  was  considered 
significant. 
 
RESULTS 
 
In Table 1 the clinical and laboratory parameters are 
reported for each group of studied subjects. All the 
parameters, including also homocysteine, folate, Vit 
B6 and Vit B12, resulted in the normal range for the 
country  of  origin  with  the  differences  reported 
already  among  African  and  Mediterranean 
populations
[16].  A  significant  difference  was  found 
between  young  and  old  people  for  blood  nitrogen, 
serum  cholesterol  and  triglycerides,  creatinine, 
cystatin C and Hcy. The level of serum folate was 
lower  in  African  subjects,  compared  to  Sardinians 
who had lower serum folate levels than Sicilians, but 
in any case all were in the normal range. The systolic 
and  diastolic  blood  pressure  was  higher  in  all  old 
studied subjects. Only in Hcy levels a difference was 
noted between males and females subjects of African 
and Mediterranean origin
[16]. The Pearson coefficient 
and Fisher exact test showed that only the age and 
creatinine  correlate  with  plasma  Hcy  (P  <  0.001), 
while  the  Vit  B6  and  Vit  B12  were  independent 
variables. Paradoxally the plasma Hcy was lower in 
Africans, where the serum folate level was also lower 
but in the normal range. The distributions of MTHFR 
677T genotype in young and old subjects, living in 
different  countries  from  sub-Saharan  to 
Mediterranean  areas  are  reported  in  Table  2.  The 
observed  vs  expected  677T  genotype  frequencies 
were  in  Hardy  Weinberg  equilibrium,  with  the 
exception  of  old  Sardinian  subjects  (P=0.02). 
Calculated  frequencies  of  677T  and  677C  alleles 
suggest  that  the  677T  allele  is  higher  in  young 
compared  to  old  subjects  in  all  the  three  studied 
areas,  although  only  the  difference  between  young 
and old African subjects was statistically significant 
(P=0.02).  The  difference  between  young  and  old 
Sardinian  subjects  had  a  marginally  significant  P 
value  (P=0.07),  whereas  the  difference  between 
young and old Sicilian subjects  was not significant 
(P=0.28).  The  retrospective  power  calculation 
showed that the size of samples was sufficient for the 
significance  level  obtained  in  Africans  and  in 
Sardinians (64% and 44% respectively), while it was 
insufficient  for  Sicilians  (19%).  The  observed 
number of African subjects with CC 1298 genotype 
was significantly higher than expected in the old age Online J. Biol. Sci., 6 (1): 28-34, 2006 
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￿ ￿￿ ￿ ￿ ￿ ￿ ￿￿ ￿￿￿ ￿ ￿￿ ￿ ￿ ￿ ￿￿ ￿￿ ￿￿ ￿ ￿- ￿￿ ￿ ￿ " ￿
￿
 group  (P=0.005),  while  the  observed  vs  expected 
genotype  frequencies  were  in equilibrium in  young 
and  old  Sardinian  and  Sicilian  subjects.  The 
frequencies  of  1298C  and  1298A  alleles  were 
comparable  between  young  and  old  African, 
Sardinian  and  Sicilian  subjects  (see  Table  3).  No 
difference  was  found  among  males  and  females  of 
each groups in C677T and A1298C polymorphisms.  
 
DISCUSSION 
 
The  aim  of  this  study  was  the  estimation  of  the 
frequency  of  MTHFR  C677T  and  A1298C 
polymorphisms in  young and old subjects living in 
Burkina  Faso,  Sardinia  and  Sicily.  It  has  been 
previously reported that the 677T allele prevalence in 
African population is lower than in Western countries 
(6.6%)
[11-13]. In European populations the prevalence 
of  the  677T  allele  ranges  from  24%  to  40%  or 
higher
[17,18].  The  frequency  of  the  1298C  allele  in 
African population was reported to be less than half 
that  of  Western  countries  (14%  vs  30%)
[3,19].  Our 
results are in good agreement  with the above cited 
literature,  and  in  particular,  the  677T  and  1298C 
allele frequencies lie at the higher values of the above 
reported ranges in Sardinians and in Sicilians, while 
they  are  comparable  in  Africans  (see  Table  2  and 
Table  3).  Table  2  shows  that  the  C677T 
polymorphism is in Hardy Weinberg equilibrium in 
both young and old subjects. The frequency of 677T 
allele in old subjects was lower in all groups studied, 
mainly  in  Africans  and  Sardinians.  The  difference 
amongst young and old subjects does not reach the 
statistical  significance  only  in  Sicilians,  probably 
because a larger sample size should be needed for so 
small differences. The observed number of  African 
subjects  with  CC  1298  genotype  was  significantly 
higher than expected in the old age group (P=0.005), 
while  the  number  of  observed  1298C  subjects  was 
clearly lower than expected (9.20% vs 25.42%). In 
Sardinian  and  Sicilian  populations  we  did  not  find 
statistically  significant  difference  between  observed 
and  expected  values  according  to  Hardy  Weinberg 
equilibrium. The plasma Hcy levels were high in old 
people both in African and in European subjects (see 
Table 1) and could correlate with increased creatinine 
levels  as  a  marker  of  renal  function  according  our 
previous findings
[20]. On the contrary the plasma Hcy 
levels were found lower in young Africans than the 
mean values found in Sardinia and in Sicily and this 
in  accord  with  our  precedent  study
[16].  This  results 
appear contradictory since we found a higher plasma 
Hcy  level  in  Mediterranean  areas  than  in  Africa, 
while  the  folate  level  was  lower  in  Africa  as 
previously reported by Amouzou et al.
[13]. If this is 
true only the low frequency of MTHFR 677T allele 
could  explain  the  low  plasma  Hcy  levels  in  young 
African  The  difference  in  the  MTHFR  alleles
Subjects  Genotype  Subjects  (N.)  Observed (%)  Expected (%)  Allele  Frequency %  
(95% CI) 
Young African  CC677  163  85.71  85.20     
  CT677  26  13.19  14.20  677C  92.00 (88%-94%) 
  TT677  2  1.10  0.59  677T  8.00 (4.7%-9.9%) 
  Total  191         
Old African  CC677  179  93.41  93.51     
  CT677  12  6.59  6.37  677C  97.00 (89%-95%) 
  TT677  0  0.00  0.1  677T  3.00 (1.8%-5.4%) 
  Total  191         
Young Sardinian  CC 677  66  33.00  32.48     
  CT 677  96  48.00  49.01  677C  57.00 (52%-62%) 
  TT 677  38  19.00  18.48  677T  43.00 (32%-48%) 
  Total  200         
Old Sardinian  CC 677  91  46.67  40.11     
  CT 677  65  33.33  46.44  677C  63.00 (58%-68%) 
  TT 677  39  20.00  13.44  677T  37.00 (32%-41%) 
  Total  195         
Young Sicilian  CC 677  60  30.85  28.86     
  CT 677  89  45.74  49.72  677C  54.00 (49%-59%) 
  TT 677  45  23.40  21.41  677T  46.00 (41%-51%) 
  Total  194         
Old Sicilian  CC 677  67  37.50  33.78     
  CT 677  74  41.25  48.67  677C  58.00 (53%-63%) 
  TT 677  39  21.25  17.53  677T  42.00 (37%-47%) 
  Total  180         Online J. Biol. Sci., 6 (1): 28-34, 2006 
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among  African  and  Mediterranean  subjects  is  not 
easily to be explained, but it is reasonable to suspect 
that social and environmental factors could advantage 
or disadvantage the selection of MTHFR genotypes. 
Probably  the  adequate  folic  acid  intake  in  a  given 
population  may  give  rise  to  an  increase  in  the 
frequency  of  the  MTHFR  677T  allele,  whereas  an 
inadequate  intake  may  results  in  decreased 
frequency.In this regards the north-to-south increase 
in the prevalence of the MTHFR 677 allele in Europe 
is  of  interest
[3,11]  and  may  be  influenced  by  the 
apparent higher folic acid content of Mediterranean 
foods  compared  with  northern  European  foods. 
Moreover,  Rosenberg  et  al.
[21]  from  haplotype 
associations suggest also a founder effect to explain 
the  expansion  of  677T  allele  in  Western  countries. 
Moreover the association of the allele T with NTD
[3], 
which is found more frequent in the North of Europe 
(Ireland and The Netherlands), but not in Sicily and 
France
[22], must be considered. The same observation 
can be made for trisomy (Down syndrome)
[6,7]. This 
considerations suggest that a early adverse event of 
infancy and no only late events, may affect the allele 
frequency.  It  has  been  also  demonstrated  that  in 
Plasmodium falciparum malaria plasma Hcy reaches 
high values which correlate with malaria severity
[14]. 
Since polyamine metabolism correlates to Hcy via S-
adenosylmethionine and plays an essential role in P. 
falciparum cell proliferation and differentiation
[23,24], 
we  hypothesize  that  an  increase  of  Hcy  levels 
associated  to  endemic  malaria  in  sub-Saharan  area 
could  represent  a  metabolic  advantage  for  the 
parasite, selecting prematurely the 677T carriers. In 
fact, it is not surprisingly to found the 677T allele 
prevalence in Sardinia, intermediate among Burkina 
Faso and Sicily, since the two Mediterranean islands 
have  had  different  pregressed  malaria  endemia. 
Moreover the difference among young and old people 
in C677T polymorphism is statistically documented 
only  in  Africa  and  in  Sardinia  (see  Table  2).  The 
lower plasma Hcy levels in subjects living in Burkina 
Faso, compared with Western subjects
[12], associated 
to low prevalence of C677T polymorphism and to a 
low incidence of hearth coronary diseases
[25], is not 
unexpected.  In  Western  countries  C677T 
polymorphism is associated to increased Hcy levels 
and stroke
[26,27], especially in presence of known risk 
factors  like  as  smoke,  alcohol,  sedentary  life 
condition,  etc
[28].  It  is  obvious  to  think  that  the 
difference among young and old people in Sardinian 
and  Sicilian  population  could  be  due  to  increased 
mortality  of  677T  carriers  for  cardiovascular 
pathologies. However it is well known that the effect 
of  HHcy  on  cardiovascular  damage  related  to  the 
MTHFR  polymorphism  is  more  evident  in  young 
than  in  old  people
[8].  The  elevated  level  of  plasma 
Subjects  Genotype  Subjects (N.)  Observed (%)  Expected (%)  Allele  Frequency % 
            (95% CI) 
Young African  AA1298  151  79.27  77.09     
  AC1298  32  17.07  21.41  1298A  87.00 (84%-90%) 
  CC1298  8  3.66  1.5  1298C  13.00 (9%- 16%) 
  Total  191         
Old African  AA1298  153  80.46  72.35     
  AC1298  15  9.20  25.42  1298A  85.00 (80%-87%) 
  CC1298  23  10.34  2.23  1298C  15.00 (13%-20%) 
  Total  191         
Young Sardinian  AA1298  106  53.00  51.84     
  AC1298  76  38.00  40.32  1298A  72.00 (67%-76%) 
  CC1298  18  9.00  7.84  1298C  28.00 (24%-32%) 
  Total  200         
Old Sardinian  AA1298  86  44.44  49.00     
  AC1298  99  51.11  42.00  1298A  70.00 (65%-74%) 
  CC1298  10  4.44  9.00  1298C  30.00 (26%-35%) 
  Total  195         
Young Sicilian  AA1298  96  48.94  50.00     
  AC1298  86  43.62  41.45  1298A  71.00 (67%-76%) 
  CC1298  12  7.45  8.55  1298C  29.00 (24%-33%) 
  Total  194         
Old Sicilian  AA1298  84  46.84  47.6     
  AC1298  78  44.30  42.78  1298A  69.00 (63%-73%) 
  CC1298  18  8.86  9.62  1298C  31.00 (27%-37%) 
  Total  180         Online J. Biol. Sci., 6 (1): 28-34, 2006 
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Hcy in old subjects, in presence of a lower prevalence 
of  C677T  polymorphism,  in  addition  of  higher 
creatinine  levels,  should  be  more  probable  the 
expression  of  glutathione  and  then  NADPH 
deficiency  typical  of  old  age
[29,30].  In  fact  this 
determines  an  increase  of  plasma  Hcy  through  an 
inhibition  of  re-methylation,  suggesting  that  non 
genetic cause of HHcy may have a greater impact and 
overwhelms the effect of a genetic polymorphism. It 
is  possible  that  MTHFR  genotype  might  affect 
behavioral  and  socioeconomic  factors  by  being 
associated  with  polymorphic  variants  of  loci  in 
linkage disequilibrium, that  predispose subject with 
TT  genotype  at  risk  of  unhealthy  behaviors,  low 
socioeconomic status, or abnormal physiological risk 
factors predisposing to stroke (such as blood pressure 
or serum cholesterol)
[31]. However folate status and 
other  environmental  exposures  could  influence  the 
Hcy  concentration,  exposing  the  individuals  to 
cardiovascular events.  
 
CONCLUSION 
 
Going  to  our  malaria  hypothesis,  old  people 
living in Africa and Sardinia should be selected for 
677T  alleles  before  the  disappearance  of  malaria. 
Studies  on  the  influence  of  677T  in  the  malaria 
outcome will clarify this difference in future. Similar 
mechanism could explain also the difference that was 
found some years ago
[32] in the prevalence of beta-
thalassemia trait among young and old people living 
in  Sicily  after  the  disappearance  of  malaria  with 
extended  use  of  DDT.  The  old  Sicilians  showed 
higher  prevalence  of  beta-thalassemia  trait  than 
younger,  since  beta-thalassemia  protects  them  from 
malaria. We think that it will be necessary to compare 
these  results  with  additional  data  from  other  areas 
where  the  malaria  has  never  been  documented  to 
verify  the  residual  effect  of  malaria  infection  in 
human genomic. 
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